OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

The purity indicated in this column was the minimum degree of purity of the active substance evaluated in accordance with Article 89(1) of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Common NameIUPAC NameIdentification NumbersMinimum degree of purity of the active substancef1 Date of approvalExpiry date of approvalProduct typeSpecific conditions
Calcium dihydroxide (hydrated lime)

IUPAC Name:

Calcium dihydroxide

EC No: 215-137-3

CAS No: 1305-62-0

800 g/kg

(the value provides the content of Ca expressed as Ca(OH)2)

1 May 201830 April 20282

The authorisations of biocidal products are subject to the following conditions:

  1. 1..

    The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.

  2. 2..

    In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to industrial and professional users.

3

The authorisations of biocidal products are subject to the following conditions:

  1. 1..

    The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.

  2. 2..

    In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to professional users.

Annotations

Footnotes

f1

The purity indicated in this column was the minimum degree of purity of the active substance evaluated in accordance with Article 89(1) of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.